Abstract
Combined radiochemotherapy is the recommended standard postoperative therapy for patients with stage II and III rectal cancer in the USA and in Germany. During the last decade, substantial progress has been made in treatment modalities: surgical management currently includes a broad spectrumof operative procedures ranging from radical operations such as abdominoperineal resections to innovative sphincter-preserving techniques. Specialized groups have reported excellent local control rates with total mesorectal excision (TME) alone without the addition of neoadjuvant or adjuvant treatment. New and improved radiation techniques using conformal radiotherapy as well as innovative chemotherapy schedules and combinations (capecitabine, oxaliplatin, irinotecan) of chemotherapy may have the potential to further increase the therapeutic benefit of (neo-)adjuvant treatment. Moreover, the basic issue of timing of radiotherapy—preoperative versus postoperative—within a multimodality regimen is currently being addressed in prospective trials. Evidently, the current monolithic approach established by studies conducted more than a decade ago, to either apply the same schedule of postoperative radiochemotherapy to all patients with UICC stage II and III rectal cancer or to give preoperative short-course radiation according to the Swedish concept for all patients with resectable rectal cancer irrespective of tumor stage and treatment goal (e.g., sphincter preservation), need to be questioned.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Beets-Tan RGH, Beets GL, Vliegen RFA et al (2001) Accuracy of magnetic resonance imaging in prediction of tumor-free resection margins in rectal cancer surgery. Lancet 357:497–504
Camma C, Giunta M, Fiorica F et al (2000) Preoperative radiotherapy for resectable rectal cancer. A meta-analysis. JAMA 248:1008–1015
Chan A, Wong A, Langevin J et al (1993) Preoperative concurrent 5-fluorouracil infusion, mitomycin C and pelvic radiation therapy in tethered and fixed rectal carcinoma. Int J Radiat Oncol Biol Phys 25:791–799
Enker WE (1997) Totalmesorectal excision—the new golden standard of surgery for rectal cancer Ann Med 29:127–133
François Y, Nemoz CJ, Baulieux J et al (1999) Influence of the interval between preoperative radiation therapy and surgery on downstaging and the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial. J Clin Oncol 17:2396–2402
Frykholm GJ, Glimelius B, Pahlman L (1993) Preoperative or postoperative irradiation in adenocarcinoma of the rectum: final treatment results of a randomized trial and an evaluation of late secondary effects. Dis Colon Rectum 36:564–572
Frykholm GJ, Pahlman L, Glimelius B (2001) Combined chemo-and radiotherapy vs. radiotherapy alone in the treatment of primary, nonresectable adenocarcinoma of the rectum. Int J Radiat Oncol Biol Phys 50:427–434
Grann A, Minsky BD, Cohen AM et al (1997) Preliminary results of preoperative 5-fluorouracil (5-FU), low dose leucovorin, and concurrent radiation therapy for resectable T3 rectal cancer. Dis Colon Rectum 40:515–522
Gunderson LL, Sargent DJ, Tepper JE et al (2002) Impact of T and N substages on survival and disease relapse in adjuvant rectal cancer: a pooled analysis. Int J Radiat Oncol Biol Phys 54:386–396
Hyams DM, Mamounas EP, Petrelli N et al (1997) A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum: a progress report of NSABP R-03. Dis Colon Rectum 40:131–139
Junginger T, Hossfeld DK, Sauer R, Hermanek P (1999): Adjuvante Therapie bei Kolon-und Rektumkarzinom. Dt Ärztebl 96:698–700
Kapiteijn E, Marijnen CAM, Nagtegaal ID et al (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345:638–648
Maghfoor I, Wilkes J, Kuvshinoff B et al (1997) Neoadjuvant chemoradiotherapy with sphinctersparing surgery for low lying rectal cancer (abstract). Proc Am Soc Clin Oncol 1997;16:274
Mannerts GH, Martijn H, Crommelin MA et al (2000) Feasibility and first results of multimodality treatment, combining EBRT, extensive surgery, and IORT in locally advanced primary rectal cancer. Int J Radiat Oncol Biol Phys 47:425–433
Marijnen CAM, Nagtegaal ID, Klein Kranenbarg E et al (2001) No downstaging after short-term preoperative radiotherapy in rectal cancer patients. J Clin Oncol 19:1976–1984
Marijnen CAM, Nagtegaal ID, Kapiteijn E et al (2003) Radiotherapy does not compensate for positive resection margins in rectal cancer patients: report of amulticenter randomized trial. Int J Radiat Oncol Biol Phys 55:1311–1320
Marsh RD, Chu NM, Vauthey JN et al (1996) Preoperative treatment of patients with locally advanced unresectable rectal adenocarcinoma utilizing continuous chronobiologically shaped 5-fluorouracil infusion and radiation therapy. Cancer 78:217–225
Minsky BD (2002). Cancer of the colon, rectum and anus. ASTRO-refresher course 2002, Course Nr. 211
Minsky BD, Cohen AM, Kemeny N et al (1992) Enhancement of radiation induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapy. J Clin Oncol 10:79–84
Nagtegaal ID, van Kriegen JHJM (2002). The role of pathologists in the quality control of diagnosis and treatment of rectal cancer—an overview. Eur J Cancer 38:964–972
NIH Consensus Conference (1990) Adjuvant therapy for patients with colon and rectal cancer. JAMA 264:1444–1450
Rau B, Wust P, Gellermann J et al (1998) Preoperative radio-chemo-thermo-therapy in locally advanced rectal cancer. Strahlenther Onkol 174:556–565
Rödel C, Sauer R (2001) Perioperative radiotherapy and concurrent radiochemotherapy in rectal cancer. Semin Surg Oncol 20:3–12
Rödel C, Grabenbauer GG, Schick CH et al (2000) Preoperative radiation with concurrent 5-fluorouracil for locally advanced T4-primary rectal cancer. Strahlenther Onkol 176:161–167
Rödel C, Grabenbauer GG, Papadopoulos T et al (2003) Phase III trial of capecitabine, oxaliplatin, and radiation for rectal cancer. J Clin Oncol 21:3098–3104
Roh MS, Petrelli N, Colangelo L et al (2001) Phase III randomized trial of preoperative versus postoperative multimodality therapy in patients with carcinoma of the rectum (NSABP R-03) (abstract). Proc Am Soc Clin Oncol 20:123a
Rouanet P, Fabre JM, Dubois JB (1995) Conservative surgery for low rectal carcinoma after high-dose radiation. Ann Surg 221:67–73
Sauer R for the German Rectal Cancer Study Group (2003) Adjuvant versus neoadjuvant combined modality treatment for locally advanced rectal cancer: first results of the German rectal cancer study (abstract 2). Int J Radiat Oncol Biol Phys 57:124
Swedish Rectal Cancer Trial (1997) Improved survival with preoperative radiotherapy in resectable rectal cancer. New Engl J Med 336:980–987
Valentini V, Coco C, Cellini N et al (1998) Preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation. Int J Radiat Oncol Biol Phys 40:1067–1072
Van de Velde CJH (2002). Preoperative radiotherapy and TME-surgery for rectal cancer: detailed analysis in relation to quality control in a randomized trial (abstract). Proc Am Soc Clin Oncol 21:127a
Videtic GM, Fisher BJ, Perera FE et al (1998) Preoperative radiation with concurrent 5-fluorouracil continuous infusion for locally advanced unresectable rectal cancer. Int J Radiat Oncol Biol Phys 42:319–324
Wagman R, Minsky BD, Cohen AM et al (1998) Sphincter preservation with preoperative radiation therapy and coloanal anastomosis: long tern follow-up. Int J Radiat Oncol Biol Phys 42:51–57
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag Berlin Hidelberg
About this paper
Cite this paper
Rödel, C., Sauer, R. (2005). Neoadjuvant Radiotherapy and Radiochemotherapy for Rectal Cancer. In: Büchler, M.W., Weitz, J., Ulrich, B., Heald, R.J. (eds) Rectal Cancer Treatment. Recent Results in Cancer Research, vol 165. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-27449-9_24
Download citation
DOI: https://doi.org/10.1007/3-540-27449-9_24
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-23341-1
Online ISBN: 978-3-540-27449-0
eBook Packages: MedicineMedicine (R0)